Show simple item record

Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs

dc.contributor.authorSanchez-Pescador, R.en_US
dc.contributor.authorLeissinger, C.en_US
dc.contributor.authorLagier, R.en_US
dc.contributor.authorLok, Anna Suk-Fongen_US
dc.contributor.authorGhany, Marc G.en_US
dc.date.accessioned2006-09-11T14:47:04Z
dc.date.available2006-09-11T14:47:04Z
dc.date.issued1996-06en_US
dc.identifier.citationGhany, M. G.; Leissinger, C.; Lagier, R.; Sanchez-Pescador, R.; Lok, A. S. F.; (1996). "Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs." Digestive Diseases and Sciences 41(6): 1265-1272. <http://hdl.handle.net/2027.42/44427>en_US
dc.identifier.issn1573-2568en_US
dc.identifier.issn0163-2116en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/44427
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8654162&dopt=citationen_US
dc.description.abstractChronic liver disease due to hepatitis C virus (HCV) infection is a major problem in hemophiliacs. Recent reports suggested that hemophiliacs coinfected with hepatitis C virus and human immunodeficiency virus (HIV) have an increased incidence of liver failure but the mechanism of accelerated liver injury is not clear. We tested plasma from 100 hemophiliacs for anti-HCV by second generation ELISA, anti-HIV by EIA, and HCV RNA and HIV RNA by branched DNA and polymerase chain reaction assays to determine if hemophiliacs coinfected with HCV and HIV have higher HCV RNA levels and more active liver disease. Seventy-nine (79%) patients were anti-HCV positive, of whom 85% were HCV RNA positive. None of the anti-HCV-negative patients had detectable HCV RNA in plasma. Forty-two (42%) patients were anti-HIV positive, of whom 47% had detectable HIV RNA. All the anti-HIV-positive patients were also anti-HCV positive. The prevalence of both anti-HCV and anti-HIV increased significantly with age. There was no difference in HCV RNA levels between anti-HIV-positive and anti-HIV-negative patients (mean: 21±4 vs 18±5 Meq/ml), although HCV RNA levels were significantly higher in anti-HIV-positive patients with CD4 counts<200/mm 3 ( P =0.008). There was an inverse correlation between HCV RNA levels and CD4 counts but no correlation was found between HCV RNA and serum aminotransferase levels. We found a high prevalence of HCV and HIV coinfection in our hemophiliacs. Hepatitis C virus replication appears to be increased in patients with severe immunodeficiency secondary to progressive HIV infection. However, there was no correlation between HCV RNA and serum ALT level, suggesting that HCV is not directly cytopathic.en_US
dc.format.extent776656 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherChronic Liver Diseaseen_US
dc.subject.otherHepatitis C Virus RNAen_US
dc.subject.otherOncologyen_US
dc.subject.otherGastroenterologyen_US
dc.subject.otherMedicine & Public Healthen_US
dc.subject.otherHepatologyen_US
dc.subject.otherTransplant Surgeryen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherHepatitis C Virusen_US
dc.subject.otherHuman Immunodeficiency Virusen_US
dc.subject.otherHemophiliaen_US
dc.titleEffect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumFrom the Section of Gastroenterology and Hepatology, and Hematology and Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana; Chiron Corporation, Emeryville, California; Division of Gastroenterology, University of Michigan Medical Center, 3912 Taubman Center, Box 0362, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherFrom the Section of Gastroenterology and Hepatology, and Hematology and Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana; Chiron Corporation, Emeryville, Californiaen_US
dc.contributor.affiliationotherFrom the Section of Gastroenterology and Hepatology, and Hematology and Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana; Chiron Corporation, Emeryville, Californiaen_US
dc.contributor.affiliationotherFrom the Section of Gastroenterology and Hepatology, and Hematology and Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana; Chiron Corporation, Emeryville, Californiaen_US
dc.contributor.affiliationotherFrom the Section of Gastroenterology and Hepatology, and Hematology and Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana; Chiron Corporation, Emeryville, Californiaen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid8654162en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/44427/1/10620_2005_Article_BF02088247.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF02088247en_US
dc.identifier.sourceDigestive Diseases and Sciencesen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.